Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
'She made me buy a saw': WRAL Investigates recording of apparent confession connected to Deven double-murder case in Fayetteville
Recommended
Check your car registration: 5 On Your Side finds hundreds of drivers paying wrong fees
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaxart Inc
(NQ:
VXRT
)
0.8852
+0.0052 (+0.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxart Inc
< Previous
1
2
3
4
5
6
7
8
Next >
High Cash Burn Will Push Vaxart Stock Down To $1 Per Share
May 14, 2021
Failed clinical trials and high cash burn mean Vaxart is headed down to cash per share levels. That suggests VXRT stock is worth just $1.
Via
InvestorPlace
Exposures
COVID-19
It Won’t Take Much for Vaxart Stock to Pop Once Again
May 14, 2021
Vaccine stocks are risky, but Americans nervous about a shot might make the difference for VXRT stock
Via
InvestorPlace
Exposures
COVID-19
Is Vaxart a Buy?
May 12, 2021
Can this troubled coronavirus vaccine developer redeem itself and its investors?
Via
The Motley Fool
Exposures
COVID-19
Vaxart’s No-Shot Vaccine Is a Potential Game Changer
May 11, 2021
VXRT stock is down from its highs, but there's no need to worry, as Vaxart has a unique Covid-19 vaccine and some encouraging clinical data.
Via
InvestorPlace
Exposures
COVID-19
Is Vaccine Maker Vaxart Worth Holding From Here?
May 09, 2021
As with most investment decisions, whether to hold depends on the situation. Here are some things to think about.
Via
The Motley Fool
Exposures
COVID-19
Better Vaccine Stock: Ocugen or Vaxart?
May 07, 2021
Here's how the biotechs compare on several key fronts.
Via
The Motley Fool
Exposures
COVID-19
58 Stocks Moving In Thursday's Mid-Day Session
May 06, 2021
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares surged 92.9% to $2.3150. Stealth BioTherapeutics presented at the Association for Research in Vision and Ophthalmology...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
30 Stocks Moving in Thursday's Pre-Market Session
May 06, 2021
Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 94.2% to $2.33 in pre-market trading. Stealth BioTherapeutics showcased data for Elamipretide in dry age-related...
Via
Benzinga
Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter?
May 06, 2021
If it can reach the market of people that are hesitant to be vaccinated, yes.
Via
The Motley Fool
Exposures
COVID-19
Vaxart Has 3 Advantages Over Pfizer and Moderna
May 06, 2021
Its coronavirus vaccine candidate may stand out, if upcoming trials are successful.
Via
The Motley Fool
Exposures
COVID-19
70 Biggest Movers From Yesterday
May 06, 2021
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters...
Via
Benzinga
64 Biggest Movers From Yesterday
May 05, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...
Via
Benzinga
Exposures
COVID-19
Why Vaxart Stock Is Surging Today
May 04, 2021
Investors are excited about the company's experimental COVID-19 vaccine.
Via
The Motley Fool
Exposures
COVID-19
44 Stocks Moving In Tuesday's Mid-Day Session
May 04, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target...
Via
Benzinga
Exposures
COVID-19
Why Vaxart Shares Popped 78% in April
May 04, 2021
Shareholders keep getting their hopes up for the company's tablet-based COVID-19 vaccine.
Via
The Motley Fool
Exposures
COVID-19
Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants
May 04, 2021
Vaxart Inc has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1.
Via
Talk Markets
Exposures
COVID-19
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
May 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 04, 2021
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7...
Via
Benzinga
Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants
May 04, 2021
Vaxart Inc (NASDAQ: VXRT) has announced new data from the Phase 1 trial evaluating its oral COVID-19 vaccine candidate, dubbed as VXA-CoV2-1. Data obtained...
Via
Benzinga
Exposures
COVID-19
26 Stocks Moving in Tuesday's Pre-Market Session
May 04, 2021
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares rose 60.5% to $1.99 in pre-market trading. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...
Via
Benzinga
Exposures
COVID-19
52 Biggest Movers From Yesterday
May 04, 2021
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 03, 2021
Gainers Precipio (NASDAQ:
Via
Benzinga
Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine
May 03, 2021
Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021...
Via
Talk Markets
Exposures
COVID-19
Mid-Afternoon Market Update: Crude Oil Rises 1.5%; AVROBIO Shares Plummet
May 03, 2021
Toward the end of trading Monday, the Dow traded up 0.82% to 34,152.49 while the NASDAQ fell 0.36% to 13,912.07. The S&P also rose, gaining 0.41% to 4,198.29. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch
May 03, 2021
Shares of Ocugen Inc. and Vaxart Inc. are moving Monday, May 3. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially effective against three key variants of...
Via
Talk Markets
Vaxart Stock Plummets On Growing Losses As Investors Eye Covid Pill
May 03, 2021
Vaxart stock plummeted Monday ahead of a key presentation for its oral Covid vaccine and after the company reported growing first-quarter losses.
Via
Investor's Business Daily
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
May 03, 2021
Gainers Precipio (NASDAQ:PRPO) stock moved upwards by 111.42% to $3.85 during Monday's regular session. The current volume of 113.0 million shares is 18552.84% of...
Via
Benzinga
2 Biopharma Stocks Looking To Make A Difference Against COVID-19: Technical Levels To Watch
May 03, 2021
Ocugen Inc. (NASDAQ: OCGN) and Vaxart Inc. (NASDAQ: VXRT) are moving Monday. Ocugen shares gapped higher after the company's studies showed that COVAXIN is potentially...
Via
Benzinga
Mid-Day Market Update: Nasdaq Drops 50 Points; Ocugen Shares Spike Higher
May 03, 2021
Midway through trading Monday, the Dow traded up 0.92% to 34,187.80 while the NASDAQ fell 0.37% to 13,910.67. The S&P also rose, gaining 0.36% to 4,196.13. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.